Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA

Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023­–September 2024. Of 995 M. pneumoniae–positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are...

Descripció completa

Dades bibliogràfiques

Autors principals:	Amy L. Leber, Tori Embry, Kathy Everhart, Jeanette Taveras, Sophonie J. Oyeniran, Huanyu Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	Centers for Disease Control and Prevention 2025-03-01
Col·lecció:	Emerging Infectious Diseases
Matèries:	Mycoplasma pneumoniae COVID-19 respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS
Accés en línia:	https://wwwnc.cdc.gov/eid/article/31/3/24-1570_article
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!